COST-EFFECTIVENESS ANALYSIS OF RHBMP-2 IN THE TREATMENT OF OPEN TIBIA FRACTURES IN THE NETHERLANDS

被引：0
|
作者：
Van Genugten, M. [1 ]
Chhabra, A. [2 ]
Alt, V [3 ]
机构：
[1] Medtron Trading NL BV, Heerlen, Netherlands
[2] Medtron Europe SA, Tolochenaz, Switzerland
[3] Univ Hosp Giessen Marburg, Brackenheim, Germany
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66795-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A544 / A544
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS OF OPEN REDUCTION NONRIGID FIXATION AND OPEN REDUCTION RIGID FIXATION TO TREAT MANDIBULAR FRACTURES
    DODSON, TB
    PFEFFLE, RC
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1995, 80 (01): : 5 - 11
  • [42] A Cost-Effectiveness Analysis of Intramedullary Nailing Versus External Fixation for Open Tibial Fractures in Tanzania
    O'Marr, Jamieson M.
    Rodarte, Patricia
    Haonga, Billy
    Ngunyale, Patrick
    Roberts, Heather
    Morshed, Saam
    Shearer, David
    JBJS OPEN ACCESS, 2025, 10 (01)
  • [43] COST-EFFECTIVENESS OF DAPAGLIFLOZIN AS ADD-ON TO INSULIN FOR THE TREATMENT OF TYPE 2 DIABETES IN THE NETHERLANDS
    van Haalen, H. G. M.
    Pompen, M.
    Bergenheim, K.
    McEwan, P.
    Townsend, R.
    Roudaut, M.
    VALUE IN HEALTH, 2013, 16 (07) : A441 - A441
  • [44] Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in the Netherlands
    Postma, MJ
    Heijnen, MLA
    Jager, JC
    PHARMACOECONOMICS, 2001, 19 (02) : 215 - 222
  • [45] OPEN FRACTURES OF THE SHAFT OF THE TIBIA - ANALYSIS OF WOUND AND FRACTURE TREATMENT
    WIDENFALK, B
    PONTEN, B
    KARLSTROM, G
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 1979, 11 (02): : 136 - 143
  • [46] COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN STABLE ANGINA PATIENTS IN THE NETHERLANDS
    Nuijten, M. J.
    Redekop, W. K.
    VALUE IN HEALTH, 2008, 11 (06) : A342 - A343
  • [47] Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The Netherlands
    Maarten J. Postma
    Marie-Louise A. Heijnen
    Johannes C. Jager
    PharmacoEconomics, 2001, 19 : 215 - 222
  • [48] Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
    Coupe, Veerle M. H.
    Meijer, Chris J. L. M.
    Berkhof, Johannes
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (05)
  • [49] Cost-effectiveness analysis of sacral neuromodulation for faecal incontinence in the Netherlands
    van Wunnik, B. P. W.
    Visschers, R. G. J.
    van Asselt, A. D. I.
    Baeten, C. G. M. I.
    COLORECTAL DISEASE, 2012, 14 (12) : e807 - e814
  • [50] Cost-effectiveness of Fosamax® (alendronate) for the treatment of osteoporosis and prevention of fractures
    Johnell, O
    Jönsson, B
    Jönsson, L
    Black, D
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S9 - S9
12345